Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per shar
-
Shares outstanding
-
22,457,615
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
480,473
-
Shares change
-
+319,366
-
Total reported value, excl. options
-
$216,693
-
Value change
-
+$147,702
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$0.451
Significant Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) as of Q4 2024
12 filings reported holding VTAK - Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar as of Q4 2024.
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 480,473 shares
of 22,457,615 outstanding shares and own 2.14% of the company stock.
Largest 10 shareholders include Warberg Asset Management LLC (310,164 shares), ARMISTICE CAPITAL, LLC (129,165 shares), XTX Topco Ltd (23,884 shares), Ground Swell Capital, LLC (10,762 shares), Tower Research Capital LLC (TRC) (6,147 shares), HARBOUR INVESTMENTS, INC. (152 shares), UBS Group AG (134 shares), BANK OF AMERICA CORP /DE/ (65 shares), Federation des caisses Desjardins du Quebec (0 shares), and Virtu Financial LLC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.